Cue Biopharma, Inc.
METHODS FOR MODULATING AN IMMUNE RESPONSE

Last updated:

Abstract:

The present disclosure provides methods of modulating an immune response in an individual. The present disclosure provides methods of treatment. The present disclosure provides methods comprising administering a multimeric polypeptide (synTac) and an immune checkpoint inhibitor to an individual. The present disclosure provides methods comprising administering a multimeric polypeptide (synTac) to an individual who is undergoing treatment with immune checkpoint inhibitor.

Status:
Application
Type:

Utility

Filling date:

19 Feb 2021

Issue date:

8 Jul 2021